AI Intelligence · across all analyzed episodes
People · top 20
Companies · top 9
Topics · top 10
AFib-induced cardiomyopathy and reversibility after rhythm controlHeart failure medication withdrawal in normalized ejection fraction patientsSinus rhythm therapy as primary treatment strategy in acute AFib/heart failureLeft atrial thrombus detection methods: TEE vs intracardiac echoPre-ablation imaging protocols and stroke risk reductionBeta-blocker efficacy differences in sinus rhythm vs atrial fibrillationCatheter ablation outcomes in AFib-related cardiomyopathyFish oil and omega-3 supplementation in AFib riskFlecainide and vernakalant as AFib conversion agentsCMR imaging for myocardial fibrosis assessment
Analyzed Episodes
Jan 16, 2026
Jan 16, 2026 This Week in Cardiology
AFib-induced cardiomyopathy and reversibility after rhythm controlHeart failure medication withdrawal in normalized ejection fraction patientsSinus rhythm therapy as primary treatment strategy in acute AFib/heart failure
View AnalysisJan 23, 2026
Jan 23 2026 This Week in Cardiology
TAVR procedural volume and operator experience outcomesMitral valve transcatheter edge-to-edge repair (M-TIER) volume-outcome relationshipsVentricular arrhythmias in older endurance athletes
View AnalysisJan 30, 2026
Jan 30 2026 This Week in Cardiology
Pulse Field Ablation (PFA) Safety and EfficacyAF Ablation Procedure OptimizationTransesophageal Echocardiography (TEE) Risk Stratification
View AnalysisFeb 6, 2026
Feb 06 2026 This Week in Cardiology
PREVENT Risk Score Validation and Racial DisparitiesOral PCSK9 Inhibitors (Enlicitide)Factor XI Inhibition in Stroke Prevention
View Analysis